Social Security Fund Updates | CSS News

by Archynetys Economy Desk

Panama Seeks Direct Negotiation for Medicine Acquisition Amid Scarcity Concerns

By Archnetys News Team


Addressing Critical Medicine Shortages: A New Approach

In a move to combat potential medicine shortages, the Panamanian Ministry of Health and the Social Security Fund are exploring direct negotiation strategies for acquiring essential pharmaceuticals. This decision comes in response to pressing needs across the nation’s healthcare system.

Urgent Action Required: Ensuring National Supply

The initiative, formalized through Online Quote No. 2025-7-0-01-08-CL-000008, signals a shift towards expedited procurement methods. the goal is to secure vital medications for the insured population and to replenish supplies in hospital centers nationwide. This approach is deemed necessary to circumvent potential disruptions in the availability of critical treatments.

The Panamanian government is actively seeking alternative acquisition mechanisms to ensure a consistent supply of medicines. This proactive measure aims to mitigate the risk of shortages and maintain the quality of care provided to citizens.

Direct Negotiation: A Viable Alternative

Direct negotiation, while not the standard procurement procedure, offers a streamlined approach to securing essential resources in times of urgent need. By engaging directly with suppliers,the Ministry of Health and the social Security Fund aim to expedite the acquisition process and ensure timely delivery of medications.

this strategy aligns with existing regulations and is specifically tailored to address the current circumstances.The focus remains on safeguarding the health and well-being of the Panamanian population by guaranteeing access to necessary medical treatments.

contextualizing the Challenge: Global Medicine Supply chains

The move towards direct negotiation highlights the increasing complexities of global medicine supply chains. According to a recent report by the World Health Organization (WHO), disruptions in manufacturing, transportation, and raw material availability can considerably impact the availability of essential medicines in various countries. Such as, the COVID-19 pandemic exposed vulnerabilities in supply chains, leading to shortages of critical medications and medical equipment worldwide.

Panama’s proactive approach reflects a growing awareness of these challenges and a commitment to ensuring the resilience of its healthcare system. By exploring alternative procurement methods, the government aims to mitigate the impact of potential disruptions and maintain a stable supply of essential medicines.

Panama, April 24, 2025

Related Posts

Leave a Comment